Page last updated: 2024-10-27

fluconazole and Allergic Bronchopulmonary Mycosis

fluconazole has been researched along with Allergic Bronchopulmonary Mycosis in 5 studies

Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.

Research Excerpts

ExcerptRelevanceReference
"We report 3 cases of allergic bronchopulmonary mycosis (ABPM) due to Schizophyllum commune."2.46[Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune]. ( Ando, T; Ikushima, S; Masunaga, A; Morimoto, K; Oritsu, M; Takemura, T, 2010)
"Despite advancements in diagnosing and treating invasive pulmonary aspergillosis (IPA), there is limited knowledge of real-world treatment pathways and medication switches."1.91Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study. ( Chastain, DB; Henao-Martínez, AF; Thompson, GR, 2023)
"Prior use of fluconazole, severe respiratory failure and hospitalization time are associated with IPA in patients with chronic pneumopathies with respiratory isolation of Aspergillus spp."1.38[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp]. ( Casal, M; Castón, JJ; Linares, MJ; Rivero, A; Torre-Cisneros, J, 2012)
"A case of allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans in a 48 year old man was discussed."1.38A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans. ( Datau, EA, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Henao-Martínez, AF1
Chastain, DB1
Thompson, GR1
Giménez, E1
Solano, C1
Nieto, J1
Remigia, MJ1
Clari, MÁ1
Costa, E1
Muñoz-Cobo, B1
Amat, P1
Bravo, D1
Benet, I1
Navarro, D1
Masunaga, A1
Morimoto, K1
Ando, T1
Ikushima, S1
Takemura, T1
Oritsu, M1
Castón, JJ1
Linares, MJ1
Rivero, A1
Casal, M1
Torre-Cisneros, J1
Datau, EA1

Reviews

1 review available for fluconazole and Allergic Bronchopulmonary Mycosis

ArticleYear
[Three cases of allergic bronchopulmonary mycosis due to Schizophyllum commune].
    Nihon Kokyuki Gakkai zasshi = the journal of the Japanese Respiratory Society, 2010, Volume: 48, Issue:12

    Topics: Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Diag

2010

Other Studies

4 other studies available for fluconazole and Allergic Bronchopulmonary Mycosis

ArticleYear
Treatment pathways, switches, and inappropriate treatment during invasive pulmonary aspergillosis: real-world experiences from a global research network study.
    Antimicrobial agents and chemotherapy, 2023, 10-18, Volume: 67, Issue:10

    Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Invasive Pulmonary Aspergillosis; Pulmonary A

2023
An investigation on the relationship between the occurrence of CMV DNAemia and the development of invasive aspergillosis in the allogeneic stem cell transplantation setting.
    Journal of medical virology, 2014, Volume: 86, Issue:4

    Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Aspergillus; Cytomegalovirus; Cytomegalo

2014
[Clinical factors associated with invasive pulmonary aspergillosis in patients with chronic pneumopathies and respiratory isolation of Aspergillus spp].
    Medicina clinica, 2012, Dec-15, Volume: 139, Issue:15

    Topics: Aged; Aged, 80 and over; Antifungal Agents; Aspergillus; Asthma; Bacterial Infections; Carrier State

2012
A patient with allergic bronchopulmonary mycosis caused by Aspergillus fumigatus and Candida albicans.
    Acta medica Indonesiana, 2012, Volume: 44, Issue:4

    Topics: Ambroxol; Anti-Bacterial Agents; Antifungal Agents; Aspergillus fumigatus; Bronchodilator Agents; Bu

2012